Document is current
Any future updates will be listed below
-
Authors
Baba, Shahid P.
Amraotkar, Alok R.
Hoetker, David
Gao, Hong
Gomes, Daniel
Zhao, Jingjing
Wempe, Michael F.
Rice, Peter J.
DeFilippis, Andrew P.
Rai, Shesh N.
Pope, C. Arden III
Bhatnagar, Aruni
O’Toole, Timothy E. https://orcid.org/0000-0003-1773-1523
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03314987 at ClinicalTrials.govDocuments that mention this clinical trial
Evaluation of supplementary carnosine accumulation and distribution: an initial analysis of participants in the Nucleophilic Defense Against PM Toxicity (NEAT) clinical trial
https://doi.org/10.1007/s00726-024-03414-5
Protocol to assess the efficacy of carnosine supplementation in mitigating the adverse cardiovascular responses to particulate matter (PM) exposure: the Nucleophilic Defense Against PM Toxicity (NEAT) trial
https://doi.org/10.1136/bmjopen-2020-039118
-
Funding
Funding for this research was provided by:
National Institutes of Health (ES019217)
- License Information
-
More Information
Article History
Received: 12 April 2024
Accepted: 20 August 2024
First Online: 31 August 2024
Declarations
:
: The authors declare no competing interests.
: This study was approved by the University of Louisville IRB (#20.0258) and all participants gave written consent.
